发明名称 THERAPIE MIT LIPOPROTEINLIPASE (LPL) VARIANT
摘要 <p>The invention provides for the use of a therapeutic derived from a truncated lipoprotein lipase protein (LPL S447X), including nucleic acids encoding such proteins, for the treatment of conditions including LPL responsive conditions, such as cardiovascular disease, hypertension, LPL deficiency, high triglyceride levels, low HDL-cholesterol levels or atherosclerosis.</p>
申请公布号 DE60039880(D1) 申请公布日期 2008.09.25
申请号 DE2000639880 申请日期 2000.06.23
申请人 AMSTERDAM MOLECULAR THERAPEUTICS B.V.;THE UNIVERSITY OF BRITISH COLUMBIA 发明人 HAYDEN, MICHAEL R.;KASTELEIN, JOHN J.;EXCOFFON, KATHERINE JULIA DIANE
分类号 A61K38/46;C12N15/09;A61K35/76;A61K48/00;A61P3/04;A61P3/10;A61P9/00;A61P9/04;A61P9/10;A61P9/12;A61P43/00;C12N9/20;C12N15/63 主分类号 A61K38/46
代理机构 代理人
主权项
地址